Related Experiment Videos
Diabetic renal disease: microalbuminuria, implications and intervention
M W Savage1, G P Leese, J P Vora
1Royal Liverpool University Hospital, United Kingdom.
Nutrition (Burbank, Los Angeles County, Calif.)
|November 1, 1995
Summary
Diabetic nephropathy progression to kidney failure can be delayed. Early intervention with angiotensin-converting enzyme inhibitors (ACEI) for microalbuminuria and aggressive blood pressure control are key strategies.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Medicine
Background:
- Diabetic nephropathy is a primary cause of end-stage renal failure.
- Proteinuria signifies established kidney damage, leading to progressive decline.
- Early intervention is crucial to delay disease progression.
Purpose of the Study:
- To review current strategies for managing diabetic nephropathy.
- To highlight the role of blood pressure and glycemic control.
- To emphasize the benefits of angiotensin-converting enzyme inhibitors (ACEI).
Main Methods:
- Review of existing literature on diabetic nephropathy management.
- Analysis of the impact of antihypertensive medications, particularly ACEI.
- Evaluation of the role of glycemic control and potential interventions like protein restriction.
Main Results:
- Aggressive blood pressure control, especially with ACEI, significantly slows glomerular filtration rate decline.
- ACEI treatment in microalbuminuric individuals reduces progression to macroalbuminuria.
- Glycemic control is most critical before microalbuminuria onset.
Conclusions:
- Aggressive treatment of hypertension is essential in diabetic nephropathy.
- ACEI are the preferred agents for managing hypertension and proteinuria.
- Improved glycemic control in normoalbuminuric stages and ACEI post-microalbuminuria onset are recommended.